Novel drug for COVID-19: Virafin a therapeutic breakthrough

نویسندگان

چکیده

Background: Pegylated Interferon Alpha-2b is synthesized via the use of PEG (polyethylene glycol). It formulated attaching a 12kDa mono methoxy polyethylene glycol moiety to recombinant human protein. acts binding (JAK/STAT) Janus kinase signal transducer and activator transcription interferon receptor. The /Virafin binds (IFNAR1/2) alpha receptor 1 2. better known as Virafin has been approved by Drugs Controller General India. This therapeutic agent currently under multicentric phase 3 trial with very promising results being reported. A single subcutaneous dose shown decrease need for oxygen therapy in patients. reduction vital factor needed provide relief Indian medical system light recent shortages faced due India’s worst wave COVID-19 cases since onset global pandemic. Alpha-2b/ confers enhanced viral clearance bolsters immune response induce quicker recovery patients mild moderate symptoms.
 Conclusion: paramount importance that further research on undertaken it can hinder progression COVID-19, reduce pressure inundated health systems, save countless lives.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Therapeutic potential of Paclitaxel against COVID-19

The coronavirus disease-2019(COVID-19) was reported in Wuhan, China, in late December 2019 and soon became the most serious global health challenge due to high rate of human-to-human transmission. The severe acute respiratory syndrome coronavirus 2(SARS-CoV-2), is a single-stranded RNA virus and belongs to the large Coronaviridae family. Paclitaxel, an antineoplastic drug extracted from the Tax...

متن کامل

A novel corona virus 2019 (COVID-19) outbreak: review article

In 2019 a newly emerged coronavirus was detected by the Center for disease control (CDC) in China. Nucleic acid sequencing from nose and throat swab samples of patients revealed that it was like severe acute respiratory syndrome coronavirus (SARS-CoV). World Health Organization (WHO) named it coronavirus disease 2019 (COVID-19) and reported more than 100000 positive tests until March 2020 for C...

متن کامل

Mucormycosis: A Lethal Phenomenon in COVID-19 Patients: A Review of Diagnostic and Therapeutic Approaches

Coronavirus disease 2019 (COVID-19) has seriously spread worldwide. One of the problems of COVID-19 patients is co-infection with other microbial infections such as fungal infections that are severely life-threatening. Mucormycosis, one of these opportunistic fungal diseases that is mistakenly known as black fungal disease, has been reported in Iran and the world. This non-systematic review is ...

متن کامل

Biomedical Application of a Novel Nanostructured-based Electrochemical Platform for Therapeutic Monitoring of an Antiepileptic Drug; Gabapentin

Herein, gold nanoparticle had been successfully synthesized through a simple, inexpensive and clean electrochemical technique. Gold nanoparticles were directly deposited on the electrode surface using an electrochemical strategy. Then, the electrochemical deposition parameters (such as applied potential and deposition time) were optimized. 1.1 V and 250 s were applied as the optimal electrodepo...

متن کامل

The Application of a Reduced Dye Used in Orthopedics as a Novel Treatment against Coronavirus (COVID-19): A Suggested Therapeutic Protocol

The severe acute respiratory syndrome caused by COVID-19 is now a global catastrophic event. Currently thereis no approved drug or vaccine for the disease. Methylene blue (MB, oxidized form, blue color) has been used inmany different areas of clinical medicine, ranging from malaria to orthopedics. Leucomethylene Blue (reduced formof MB, colorless) may be applied for the treatm...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Biomedical Sciences

سال: 2021

ISSN: ['2382-5545']

DOI: https://doi.org/10.3126/jbs.v8i1.38456